Preserving the Balance in Stroke Prevention: Brain, Heart and Kidneys (symposium summary sponsored by Bayer)

Author:Graeme J. Hankey, Hendrik Bonnemeier, Mike Sharma
Volume Info:Volume 5 Issue 1
Article Information

Volume 5 Issue 1, pages 52-61
Received – 24th July 2019, Accepted – 26th July 2019


Medical School, The University of Western Australia, Perth, Australia.


University Clinic Schleswig-Holstein, Department für Rhythmology and Electrophysiology, Arnold-Heller-Str. 3, 24105 Kiel, Germany


McMaster University / Population Health Research Institute, 237 Barton Street East, HGH-DBCVSRI C4-120, Hamilton, Ontario, L8L 2X2, Canada.

Corresponding Author: Allison Kirsop –


Stroke is the second leading cause of death after ischaemic heart disease, and the second leading cause of Disability Adjusted Life Years (DALYs) lost globally. A holistic approach to the prevention and management of stroke can reduce stroke-related mortality and morbidity.The association between diabetes, atrial fibrillation, and renal disease as risk factors for stroke are discussed in this meeting summary. The results of phase 3 trials for anticoagulation therapy are reviewed and presented in the context of defining high-risk patients for stroke and cardiovascular disease.


Acknowledgements: We thank Dr Allison Kirsop and Oruen Ltd. for editorial assistance in the preparation of this manuscript.


Atrial Fibrillation, Cardiovascular Disease, Chronic Kidney Disease, Diabetes, Ischaemic Heart Disease, Stroke



Keep up to date with our latest
articles and journals